Andrea Malone

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

Journal: Blood advances
Published: May 07, 2026

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia
Published: October 06, 2025

Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent years.

Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent years.

Journal: Blood advances
Published: September 09, 2025

Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

Journal: Blood advances
Published: September 09, 2025

Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus.

Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus.

Journal: Clinical epigenetics
Published: June 02, 2025

Paediatric lymphoblastic lymphoma: a national review of 20 years of clinical and biological data in Ireland.

Paediatric lymphoblastic lymphoma: a national review of 20 years of clinical and biological data in Ireland.

Journal: Annals of hematology
Published: January 07, 2025

Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.

Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.

Journal: Blood cancer journal
Published: December 13, 2024

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Journal: British journal of haematology
Published: August 05, 2024

A novel TCF3::PIK3R1 fusion linked to decreased PI3K-AKT signalling activity in paediatric B-acute lymphoblastic leukaemia.

A novel TCF3::PIK3R1 fusion linked to decreased PI3K-AKT signalling activity in paediatric B-acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: April 23, 2024

MRD-risk stratification mitigates TLX3 prognostic impact in paediatric T-cell acute lymphoblastic leukaemia: A national cohort analysis.

MRD-risk stratification mitigates TLX3 prognostic impact in paediatric T-cell acute lymphoblastic leukaemia: A national cohort analysis.

Journal: British journal of haematology
Published: March 07, 2024

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 15, 2023

Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis.

Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis.

Journal: Leukemia & lymphoma
Published: November 01, 2023
Showing 1-12 of 21

Last Updated: 09/26/2026